Changeflow GovPing Healthcare Center for Scientific Review Notice of Closed M...
Routine Notice Added Final

Center for Scientific Review Notice of Closed Meetings

Favicon for www.federalregister.gov FR: National Institutes of Health
Published
Detected
Email

Summary

The National Institutes of Health Center for Scientific Review announces five closed meetings scheduled for May 12-13, 2026. The meetings will review and evaluate grant applications for clinical vision research, reproductive/perinatal/pediatric health, contraceptive development, immunity/host defense, and aging tissue research. Meetings are closed under provisions of the Federal Advisory Committee Act because discussions could disclose confidential trade secrets, commercial property such as patentable material, and personal information of individuals associated with grant applications.

What changed

NIH published a Federal Register notice announcing five closed meetings of the Center for Scientific Review scheduled for May 12-13, 2026. The meetings will review grant applications for various research areas including clinical vision research, reproductive health, contraceptive development, immunity research, and aging tissue studies. All meetings will be held virtually.

Affected parties seeking information about NIH grant review outcomes should note that these meetings are closed to the public pursuant to 5 U.S.C. sections 552b(c)(4) and 552b(c)(6) to protect confidential trade secrets, patentable material, and personal privacy information of grant applicants. Contact information for Scientific Review Officers is provided for each meeting.

What to do next

  1. Monitor NIH CSR meeting schedules for grant application updates
  2. Contact listed Scientific Review Officers for additional information on closed meetings

Archived snapshot

Apr 15, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Notice

Center for Scientific Review; Notice of Closed Meetings

A Notice by the National Institutes of Health on 04/15/2026

  • PDF

  • Document Details

  • Document Dates

- Table of Contents

  • Public Comments
  • Regulations.gov Data

- Sharing

  • Print
  • Other Formats
  • Public Inspection Published Document: 2026-07291 (91 FR 20176) Document Headings ###### Department of Health and Human Services
National Institutes of Health

Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR Panel: Review for Clinical Vision Research UG1 Applications.

Date: May 12, 2026.

Time: 9:00 a.m. to 6:00 p.m.

Agenda: To review and evaluate grant applications.

Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.

Meeting Format: Virtual Meeting.

Contact Person: Victor Henriquez, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 435-0813, victor.henriquez@nih.gov.

Name of Committee: Population Sciences and Epidemiology Integrated Review Group; Reproductive, Perinatal and Pediatric Health Study Section.

Date: May 12-13, 2026.

Time: 9:30 a.m. to 6:00 p.m.

Agenda: To review and evaluate grant applications.

Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.

Meeting Format: Virtual Meeting.

Contact Person: Sheila Pirooznia, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 496-9350, sheila.pirooznia@nih.gov.

Name of Committee: Center for Scientific Review Special Emphasis Panel; Contraceptive Development Research Centers P50.

Date: May 12-13, 2026.

Time: 9:30 a.m. to 8:00 p.m.

Agenda: To review and evaluate grant applications.

Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.

Meeting Format: Virtual Meeting.

Contact Person: Anthony Wing Sang Chan, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 809K, Bethesda, MD 20892, (301) 496-9392, chana3@csr.nih.gov.

Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Immunity and Host Defense.

Date: May 12, 2026.

Time: 10:00 a.m. to 2:00 p.m.

Agenda: To review and evaluate grant applications.

Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.

Meeting Format: Virtual Meeting.

Contact Person: Mairi Noverr, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (240) 747-7530, mairi.noverr@nih.gov.

Name of Committee: Center for Scientific Review Special Emphasis Panel; RFA-AG-26-014: Aging Mammalian Tissues In Vitro (R21).

Date: May 12, 2026.

Time: 10:00 a.m. to 6:00 p.m.

Agenda: To review and evaluate grant applications.

Address: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892.

Meeting Format: Virtual Meeting.

Contact Person: Joonil Seog, SCD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301-402-9791, joonil.seog@nih.gov.

Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Topics in Hepatology, Pharmacology and Toxicology.

Date: May 12, 2026.

Time: 10:00 a.m. to 5:30 p.m.

Agenda: To review and evaluate grant applications.

Address: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892.

Meeting Format: Virtual Meeting.

Contact Person: M. Lourdes Ponce, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594-3919, lourdes.ponce@nih.gov.

Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Cognitive, Visual and Circadian Neuroscience.

Date: May 12, 2026.

Time: 10:00 a.m. to 6:00 p.m.

Agenda: To review and evaluate grant applications.

Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.

Meeting Format: Virtual Meeting.

Contact Person: Alena Valeryevna Savonenko, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 1009J, Bethesda, MD 20892, (301) 594-3444, savonenkoa2@csr.nih.gov.

Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR Panel: Non-Human Primate Research Resources and Infrastructure, and Development of Animal Models for Research.

Date: May 12, 2026.

Time: 11:00 a.m. to 3:00 p.m.

Agenda: To review and evaluate grant applications.

Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.

Meeting Format: Virtual Meeting.

Contact Person: Zhuqing Li, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (240) 669-5068, zhuqing.li@nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS)

Dated: April 10, 2026.

Sterlyn H. Gibson,

Program Specialist, Office of Federal Advisory Committee Policy.

[FR Doc. 2026-07291 Filed 4-14-26; 8:45 am]

BILLING CODE 4140-01-P

Published Document: 2026-07291 (91 FR 20176)

Named provisions

Federal Advisory Committee Act provisions 552b(c)(4) and 552b(c)(6)

Get daily alerts for FR: National Institutes of Health

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from Health and Human Services Department.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
Health and Human Services Department
Published
April 15th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
91 FR 20176

Who this affects

Applies to
Healthcare providers Educational institutions Government agencies
Industry sector
5417 Scientific Research
Activity scope
Grant review Scientific peer review NIH committee meetings
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Compliance
Topics
Public Health Scientific Research

Get alerts for this source

We'll email you when FR: National Institutes of Health publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!